These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12464456)

  • 1. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.
    Taffe MA; Davis SA; Yuan J; Schroeder R; Hatzidimitriou G; Parsons LH; Ricaurte GA; Gold LH
    Neuropsychopharmacology; 2002 Dec; 27(6):993-1005. PubMed ID: 12464456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys.
    Taffe MA; Huitrón-Resendiz S; Schroeder R; Parsons LH; Henriksen SJ; Gold LH
    Pharmacol Biochem Behav; 2003 Aug; 76(1):141-52. PubMed ID: 13679227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Taffe MA; Weed MR; Davis S; Huitrón-Resendiz S; Schroeder R; Parsons LH; Henriksen SJ; Gold LH
    Neuropsychopharmacology; 2001 Mar; 24(3):230-9. PubMed ID: 11166514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.
    Frederick DL; Ali SF; Slikker W; Gillam MP; Allen RR; Paule MG
    Neurotoxicol Teratol; 1995; 17(5):531-43. PubMed ID: 8551999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
    Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
    Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS; Woolverton WL; Seiden LS
    Brain Res; 1989 May; 488(1-2):121-5. PubMed ID: 2472850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
    Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM
    Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.
    McCann UD; Mertl M; Eligulashvili V; Ricaurte GA
    Psychopharmacology (Berl); 1999 Apr; 143(4):417-25. PubMed ID: 10367560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF; Newport GD; Scallet AC; Binienda Z; Ferguson SA; Bailey JR; Paule MG; Slikker W
    Neurotoxicol Teratol; 1993; 15(2):91-6. PubMed ID: 7685472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.
    McCann UD; Peterson SC; Ricaurte GA
    Neuropsychopharmacology; 2007 Aug; 32(8):1695-706. PubMed ID: 17203011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
    Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
    Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation.
    Mechan AO; O'Shea E; Elliott JM; Colado MI; Green AR
    Psychopharmacology (Berl); 2001 Jun; 155(4):413-8. PubMed ID: 11441431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
    Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMA self-administration fails to alter the behavioral response to 5-HT(1A) and 5-HT(1B) agonists.
    Aronsen D; Schenk S
    Psychopharmacology (Berl); 2016 Apr; 233(7):1323-30. PubMed ID: 26856854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD; Eligulashvili V; Ricaurte GA
    Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.
    Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K
    J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.